JP2020515620A5 - - Google Patents

Download PDF

Info

Publication number
JP2020515620A5
JP2020515620A5 JP2019554003A JP2019554003A JP2020515620A5 JP 2020515620 A5 JP2020515620 A5 JP 2020515620A5 JP 2019554003 A JP2019554003 A JP 2019554003A JP 2019554003 A JP2019554003 A JP 2019554003A JP 2020515620 A5 JP2020515620 A5 JP 2020515620A5
Authority
JP
Japan
Prior art keywords
salt
dihydrospiro
oxo
cyclohexane
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019554003A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020515620A (ja
JP7063915B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2018/014502 external-priority patent/WO2018182051A1/en
Publication of JP2020515620A publication Critical patent/JP2020515620A/ja
Publication of JP2020515620A5 publication Critical patent/JP2020515620A5/ja
Application granted granted Critical
Publication of JP7063915B2 publication Critical patent/JP7063915B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019554003A 2017-03-30 2018-03-29 Ip6k阻害剤 Active JP7063915B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017066579 2017-03-30
JP2017066579 2017-03-30
PCT/JP2018/014502 WO2018182051A1 (en) 2017-03-30 2018-03-29 Ip6k inhibitors

Publications (3)

Publication Number Publication Date
JP2020515620A JP2020515620A (ja) 2020-05-28
JP2020515620A5 true JP2020515620A5 (cg-RX-API-DMAC7.html) 2021-05-06
JP7063915B2 JP7063915B2 (ja) 2022-05-09

Family

ID=62134158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019554003A Active JP7063915B2 (ja) 2017-03-30 2018-03-29 Ip6k阻害剤

Country Status (23)

Country Link
US (1) US10968178B2 (cg-RX-API-DMAC7.html)
EP (1) EP3601256A1 (cg-RX-API-DMAC7.html)
JP (1) JP7063915B2 (cg-RX-API-DMAC7.html)
KR (1) KR102597117B1 (cg-RX-API-DMAC7.html)
CN (1) CN110461828B (cg-RX-API-DMAC7.html)
AR (1) AR111307A1 (cg-RX-API-DMAC7.html)
AU (1) AU2018246053B2 (cg-RX-API-DMAC7.html)
CA (1) CA3057821A1 (cg-RX-API-DMAC7.html)
CL (1) CL2019002662A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019012125A2 (cg-RX-API-DMAC7.html)
EA (1) EA038177B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP19077969A (cg-RX-API-DMAC7.html)
IL (1) IL269347B2 (cg-RX-API-DMAC7.html)
JO (1) JOP20180029A1 (cg-RX-API-DMAC7.html)
MA (1) MA49006A (cg-RX-API-DMAC7.html)
MX (1) MX393896B (cg-RX-API-DMAC7.html)
PE (1) PE20191656A1 (cg-RX-API-DMAC7.html)
PH (1) PH12019502248A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201908894SA (cg-RX-API-DMAC7.html)
TW (1) TWI778038B (cg-RX-API-DMAC7.html)
UA (1) UA125445C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018182051A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201907136B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX389798B (es) 2017-01-20 2025-03-20 Arcus Biosciences Inc Azolopirimidina para el tratamiento de trastornos relacionados con el cáncer.
MX2019010302A (es) 2017-03-30 2019-11-21 Hoffmann La Roche Isoquinolinas como inhibidores de hpk1.
CA3090922A1 (en) 2018-02-16 2019-08-22 Arcus Biosciences, Inc. Dosing with an azolopyrimidine compound
JP7386841B2 (ja) 2018-07-24 2023-11-27 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト イソキノリン化合物及びその使用
TW202024053A (zh) 2018-10-02 2020-07-01 美商建南德克公司 異喹啉化合物及其用途
TW202023558A (zh) 2018-10-03 2020-07-01 美商建南德克公司 8-胺基異喹啉化合物及其用途
JP7690493B2 (ja) * 2020-05-04 2025-06-10 大鵬薬品工業株式会社 Iapアンタゴニスト化合物及びその中間体、並びにそれを合成する方法
UY39609A (es) * 2021-01-12 2022-08-31 Servier Lab Nuevos derivados de espirociclohexano, composiciones farmacéuticas que los contienen y sus usos como inhibidores antiapoptóticos
CA3250650A1 (en) * 2022-02-11 2023-08-17 The University Of North Carolina At Chapel Hill ARYLBENZOISOXAZOLE COMPOUNDS USED AS IP6K AND IPMK INHIBITORS AND THEIR METHODS OF USE
US20250346572A1 (en) * 2022-06-16 2025-11-13 Lieber Institute, Inc. Non-acid inhibitors of inositol hexakisphosphate kinase (ip6k) and methods of use thereof
CN115747325A (zh) * 2022-11-10 2023-03-07 上海交通大学医学院附属新华医院 Ip6k1及其产物作为增加血液脂联素药物靶点的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617302A (en) * 1984-10-15 1986-10-14 Eli Lilly And Company Inotropic agents
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
US7045527B2 (en) * 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
BR0315815A (pt) 2002-11-01 2005-09-13 Takeda Pharmaceutical Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
US7820837B2 (en) 2003-05-30 2010-10-26 Takeda Pharmaceutical Company Limited Condensed ring compound
US7456218B2 (en) 2003-12-25 2008-11-25 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl) propanoic acid derivatives
WO2005063725A1 (ja) 2003-12-26 2005-07-14 Takeda Pharmaceutical Company Limited フェニルプロパン酸誘導体
WO2005087710A1 (ja) 2004-03-15 2005-09-22 Takeda Pharmaceutical Company Limited アミノフェニルプロパン酸誘導体
JP4859665B2 (ja) 2004-03-30 2012-01-25 武田薬品工業株式会社 アルコキシフェニルプロパン酸誘導体
US8957070B2 (en) 2005-04-20 2015-02-17 Takeda Pharmaceutical Company Limited Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
EP1916234B1 (en) 2005-07-29 2014-11-12 Takeda Pharmaceutical Company Limited Cyclopropanecarboxylic acid compound
US20090054435A1 (en) 2005-07-29 2009-02-26 Hiroshi Imoto Phenoxyalkanoic Acid Compound
JP4094660B1 (ja) 2005-08-10 2008-06-04 武田薬品工業株式会社 糖尿病治療剤
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
AU2007265966B2 (en) 2006-06-27 2012-05-17 Takeda Pharmaceutical Company Limited Fused cyclic compounds
EP2298772A1 (en) 2006-10-18 2011-03-23 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds
CN101573357B (zh) 2006-10-19 2013-01-23 武田药品工业株式会社 吲哚化合物
WO2008093639A1 (ja) 2007-01-29 2008-08-07 Takeda Pharmaceutical Company Limited ピラゾール化合物
AU2008215490A1 (en) 2007-02-09 2008-08-21 Takeda Pharmaceutical Company Limited Fused ring compounds as partial agonists of PPAR-gamma
JPWO2008136428A1 (ja) 2007-04-27 2010-07-29 武田薬品工業株式会社 含窒素5員複素環化合物
EP2157859A4 (en) 2007-06-19 2011-01-12 Takeda Pharmaceutical INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE
EP2108641A1 (en) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
JP6453507B2 (ja) 2017-03-30 2019-01-16 アムジエン・インコーポレーテツド Mcl−1タンパク質を阻害する化合物
MX2019010302A (es) 2017-03-30 2019-11-21 Hoffmann La Roche Isoquinolinas como inhibidores de hpk1.

Similar Documents

Publication Publication Date Title
AU2019301628B2 (en) Pyridine carboxamide compounds for inhibiting NaV1.8
AU2019373244B2 (en) Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
AU2019302534B2 (en) Pyridazine compounds for inhibiting NaV1.8
AU2016226340B2 (en) Bicyclic ketone sulfonamide compounds
JP6636014B2 (ja) Rafキナーゼ阻害剤としての化合物および組成物
US10023591B2 (en) Heterocyclic derivatives and use thereof
JP2016525075A5 (cg-RX-API-DMAC7.html)
JP2017508789A5 (cg-RX-API-DMAC7.html)
KR20260070403A (ko) Pi3k 억제제로서의 벤조피리디논 및 벤조피리미디논
JP2018525375A5 (cg-RX-API-DMAC7.html)
JP2017502940A5 (cg-RX-API-DMAC7.html)
RU2018103944A (ru) Производные этинила как модуляторы метаботропного рецептора глутамата
JP2019094350A (ja) 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP6771246B2 (ja) それに関連する障害の治療または予防に有用なβ−3アドレナリン受容体調節剤
JP2019516759A (ja) がんの処置のためのピラゾロピリジン誘導体
JP2020512387A5 (cg-RX-API-DMAC7.html)
TW202126651A (zh) 吡啶酮化合物及使用方法
JP2015509098A5 (cg-RX-API-DMAC7.html)
JP2017530176A (ja) 治療用化合物およびその使用
RU2018134981A (ru) Конъюгаты, содержащие ингибиторы RIPK2
JP2019524763A5 (cg-RX-API-DMAC7.html)
TW202404969A (zh) 用於治療疼痛之雜芳基化合物
RU2012127808A (ru) Производные 2-пиридона
AU2015222917A1 (en) Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
TW200904817A (en) Compounds and uses thereof